Collectively, these observations indicate that at least in breast cancer cells, NFIB overexpression has a potential to cause genomic aberrations that could ultimately lead to carcinogenesis, supporting the role of NFIB in genome organization and replication initiation. The gene discussed is NFIB; the disease is breast carcinoma.